Summary & Overview
CPT 81596: HCV Liver Fibrosis and Necroinflammation Prognostic Score
CPT code 81596 represents a combined laboratory and algorithmic analysis service that generates a prognostic score for liver fibrosis and necroinflammation in patients with chronic hepatitis C virus (HCV) infection. This test integrates six biochemical assay results with patient data to produce a clinically actionable prognostic metric, supporting disease staging and management decisions. Nationally, utilization of algorithm-driven laboratory tests like CPT code 81596 is relevant for precision medicine initiatives, value-based care pathways, and payer coverage policies for infectious liver disease.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise overview of clinical context, expected sites of service, and the function of the test. The publication also provides benchmark-oriented content addressing coding and billing considerations, payer coverage patterns, and policy implications for laboratory-developed prognostic assays. The material is intended for national audiences including billing professionals, laboratory directors, clinical leaders, and policy analysts seeking clarity on what CPT code 81596 represents, how it is used in clinical workflows, and the payer landscape relevant to this assay.
Data not available in the input for payer-specific reimbursement rates, associated taxonomies, and ICD-10 mappings.
Billing Code Overview
CPT code 81596 describes a laboratory service in which a lab analyst performs technical testing for six biochemical assays and applies an algorithmic analysis to combine patient data and those test results into a prognostic score for liver fibrosis and necroinflammation in patients with chronic hepatitis C virus (HCV) infection.
-
Service type: Laboratory diagnostic assay with algorithmic prognostic reporting
-
Typical site of service: Clinical laboratory or reference laboratory (specimen collection may occur in outpatient phlebotomy, clinic, or hospital settings)
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient with chronic hepatitis C virus (HCV) infection is referred by their hepatology clinic for laboratory-based noninvasive assessment of liver fibrosis and necroinflammatory activity. The clinician orders a blood draw; the clinical laboratory performs six biochemical assays (commonly including aminotransferases, platelets, bilirubin, and other analytes required by the specific proprietary algorithm) and the lab analyst runs the algorithmic analysis to generate a prognostic score for liver fibrosis and necroinflammation. The typical workflow: the patient presents to an outpatient phlebotomy clinic or hospital laboratory; venous blood is collected and processed; the technical component consists of performing the six assays, performing quality control, and uploading results into the algorithmic software; the lab analyst validates analytic performance and releases the final report with the prognostic score to the ordering hepatologist. Typical site of service: outpatient laboratory or hospital clinical laboratory. Service type: laboratory diagnostic test with algorithmic interpretation and reporting of a validated prognostic score for hepatic fibrosis/necroinflammation in chronic HCV.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the professional component of a testing service if applicable (e.g., physician interpretation separate from technical lab work). |